Home › Ovarian Epithelial Carcinoma › Texas › Houston

Ovarian Epithelial Carcinoma clinical trials in Houston, TX

6 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

RecruitingPhase 2

Houston Methodist Hospital /ID# 274568, Houston

Ages 18 and older · Women · Updated Sep 29, 2026 · NCT06890338

A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer

RecruitingPhase 1

Site 0103, Houston

Ages 18 and older · Women · Updated Apr 7, 2026 · NCT04516447

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

RecruitingPhase 1/2

MD Anderson Cancer Center, Houston

Ages 18 and older · All sexes · Updated Mar 27, 2026 · NCT06395519

A Study of NX-1607 in Adults With Advanced Malignancies

RecruitingPhase 1

MD Anderson Cancer Center, Houston

Ages 18 and older · All sexes · Updated Sep 9, 2025 · NCT05107674

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

RecruitingPhase 1

MD Anderson Cancer Center, Houston

Ages 18 and older · All sexes · Updated Aug 15, 2025 · NCT04429542

BP1001-A in Patients With Advanced or Recurrent Solid Tumors

RecruitingPhase 1

The University of Texas M.D. Anderson Cancer Center, Houston

Ages 18 and older · All sexes · Updated Mar 7, 2025 · NCT04196257

Ovarian Epithelial Carcinoma trials in other cities

Other studies in Houston

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.